Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,081 | 19,807 | 10,479 | 16,615 | 31,299 |
| Marketable Securities | N/A | N/A | N/A | 2,099 | N/A |
| Other current assets | 268 | 233 | 184 | 356 | 392 |
| TOTAL | $23,349 | $20,040 | $10,663 | $19,070 | $31,691 |
| Non-Current Assets | |||||
| PPE Net | 47 | 87 | 156 | 232 | 215 |
| Other Non-Current Assets | 90 | 12 | 12 | 0 | 12 |
| TOTAL | $137 | $99 | $168 | $232 | $227 |
| Total Assets | $23,486 | $20,139 | $10,831 | $19,302 | $31,918 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 453 | 294 | 424 | 303 | 1,034 |
| Accrued Expenses | 835 | 217 | 708 | 362 | 1,517 |
| Other current liabilities | 9 | N/A | N/A | N/A | N/A |
| TOTAL | $1,387 | $511 | $1,132 | $665 | $2,551 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,387 | $511 | $1,132 | $665 | $2,551 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,730 | 17,219 | 6,596 | 6,594 | 6,539 |
| Common Shares | 22 | 17 | 7 | 7 | 46 |
| Retained earnings | -168,587 | -163,956 | -157,399 | -145,488 | -130,638 |
| TOTAL | $22,099 | $19,628 | $9,699 | $18,637 | $29,367 |
| Total Liabilities And Equity | $23,486 | $20,139 | $10,831 | $19,302 | $31,918 |